Impact BioMedical Inc.
IBO
$0.45
-$0.0225-4.76%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.15M | 1.95M | 1.49M | 1.20M | 1.33M |
| Depreciation & Amortization | 1.12M | 1.12M | 1.12M | 1.12M | 1.12M |
| Other Operating Expenses | 285.00K | 173.00K | 161.00K | 122.00K | 114.00K |
| Total Operating Expenses | 3.64M | 3.40M | 3.66M | 3.61M | 4.00M |
| Operating Income | -3.64M | -3.40M | -3.66M | -3.61M | -4.00M |
| Income Before Tax | -25.02M | -24.74M | 1.10M | -4.32M | -4.56M |
| Income Tax Expenses | 33.00K | 33.00K | -- | -- | -- |
| Earnings from Continuing Operations | -25.05 | -24.77 | 1.10 | -4.32 | -4.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 37.00K | 62.00K | 63.00K | 72.00K | 96.00K |
| Net Income | -25.02M | -24.71M | 1.16M | -4.25M | -4.46M |
| EBIT | -3.64M | -3.40M | -3.66M | -3.61M | -4.00M |
| EBITDA | -3.63M | -3.39M | -3.66M | -3.61M | -3.99M |
| EPS Basic | -2.18 | -2.17 | 0.14 | -0.24 | -0.17 |
| Normalized Basic EPS | 0.02 | 0.02 | 0.09 | -0.15 | -0.10 |
| EPS Diluted | -2.50 | -2.49 | -0.18 | -0.26 | -0.19 |
| Normalized Diluted EPS | -0.18 | -0.17 | -0.10 | -0.15 | -0.10 |
| Average Basic Shares Outstanding | 45.07M | 43.01M | 61.01M | 120.00M | 180.50M |
| Average Diluted Shares Outstanding | 105.57M | 103.51M | 121.50M | 120.00M | 180.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |